Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, May 5 2025

Full Issue

Major Supplier Of Medical Products Adding Surcharge To US Shipments

MilliporeSigma says the extra fees, which will take effect Monday, are a direct response to President Donald Trump's tariffs. The company is owned by Merck KGaA, which is based in Germany.

MilliporeSigma, one of the largest suppliers of medical research products, will start adding a temporary tariff surcharge to all product orders shipped to the United States. (Silverman, 5/2)

Major medtech companies are wasting no time implementing strategies — ranging from moving production to stocking up on inventory — to mitigate the big blow each of them expects from tariffs. Raising prices to the hospitals and health systems they sell to is viewed as a last resort, executives said during recent quarterly earnings calls. (Dubinsky, 5/2)

More health care and pharma news —

UnitedHealth Group and Amedisys have agreed to sell certain home health and hospice locations to BrightSpring Health Services and The Pennant Group to help mitigate antitrust concerns over the insurer’s planned acquisition of Amedisys. Amedisys disclosed the proposed divestitures in a filing with the Securities and Exchange Commission earlier this week, but the company did not include the number of locations the Baton Rouge, Louisiana-based home care provider or UnitedHealth Group plan to sell or the financial terms. (Eastabrook, 5/2)

Big for-profit health systems are seeing double-digit growth in exchange volumes, signaling a larger industry trend as the number of enrollees balloons to record highs. At least 24.2 million people purchased insurance on the Affordable Care Act exchange marketplaces during open enrollment for 2025, beating the record 21.3 million people in 2024, according to the Centers for Medicare and Medicaid Services. The increase is showing up in health systems' latest financial reports and catching interest from analysts on first-quarter earnings calls, largely due to continued uncertainty surrounding ACA subsidies. (Hudson, 5/2)

Dr. Karen DeSalvo is leaving Google after more than five years as the company's first chief health officer. DeSalvo in a Friday LinkedIn post said she is departing Google this summer. She will retire after nearly 35 years in various healthcare leadership roles, including a stint as the National Coordinator for Health Information Technology under President Barack Obama. (Perna, 5/2)

GE HealthCare said Friday it received Food and Drug Administration clearance for its artificial intelligence tool that uses deep learning to outline organs at risk in MRI images and help improve radiation therapy planning. MR Contour DL can outline 37 organs and structures in the head-neck and pelvic areas. The process previously had to be done manually. (Dubinsky, 5/2)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ